8-K
Current Report
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001628280-21-021025
Material agreement
- Item 1.01 Entry into a material definitive agreement
From the SEC's structured data for this filing
Loading cpix-20211101.htm…